A Phase IV Study of Huazhi Rougan Granule in the Treatment of

Updated 05/14/2024

Status Completed

Clinical Trial Summary

An open Label, Single-arm, Multicenter phase IV study; There was a 2-week screening period and a 12-week / 24-week treatment period

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06202456
Study type	Interventional
Source	Shandong New Time Pharmaceutical Co., LTD
Contact
Status	Completed
Phase	Phase 4
Start date	May 13, 2020
Completion date	June 9, 2022

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT04759534` - Application of PCSK9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia	Phase 3
	Not yet recruiting	`NCT05532111` - Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial	N/A
	Active, not recruiting	`NCT04284215` - Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC	N/A
	Completed	`NCT04870606` - Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness	Phase 3
	Completed	`NCT03660761` - Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors	Phase 2
	Active, not recruiting	`NCT03794778` - Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer	Phase 4
	Recruiting	`NCT03255343` - Treatment of Non-responding to Conventional Therapy Inoperable Liver Cancers by in Situ Introduction of ImDendrim	N/A
	Recruiting	`NCT04197544` - Evaluation of the Implantation of the End-vascular Creation of the Arteriovenous Fistulas in Patients in the University Hospital of Araba. Pilot Study.	N/A
	Recruiting	`NCT04518501` - Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer	Phase 1/Phase 2
	Completed	`NCT03779776` - The Efficacy and Safety of Early Vitamin AD Supplementation in Very Preterm Infants	N/A
	Not yet recruiting	`NCT06218004` - Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma	Phase 2
	Enrolling by invitation	`NCT02809079` - Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients	Phase 4
	Recruiting	`NCT06194188` - A Phase 2 Clinical Study of CU-20401	Phase 2
	Recruiting	`NCT03901235` - MSC Intratissular Injection in Crohn Disease Patients	Phase 1/Phase 2
	Completed	`NCT03826004` - Clemastine in Cardiovascular Surgery	N/A
	Active, not recruiting	`NCT03623776` - Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.	Phase 2
	Recruiting	`NCT04078399` - Efficacy and Safety of Azacitidine Combined With Interferon in the Treatment of Post-transplant Recurrence	N/A
	Not yet recruiting	`NCT06383078` - HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer	Phase 2
	Withdrawn	`NCT05481775` - Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer	Phase 2